Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
87146154 |
LAW OFFICE ASSIGNED |
LAW OFFICE 112 |
MARK SECTION |
MARK |
TASPIANCE |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
TASPIANCE |
OWNER SECTION |
NAME |
GENENTECH, INC. |
STREET |
1 DNA WAY |
CITY |
SOUTH SAN FRANCISCO |
STATE |
California |
ZIP/POSTAL CODE |
94080-4990 |
COUNTRY |
United States |
PHONE |
650-467-1936 |
FAX |
650-952-9881 |
EMAIL |
docketing-d@gene.com |
owner-curr AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations for treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and
disorders, angiogenesis diseases and disorders, ocular diseases and disorders, inflammatory diseases and disorders, gastro-intestinal diseases and disorders, respiratory diseases and disorders,
neurological diseases and disorders, infectious diseases and disorders, metabolic diseases and disorders |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
3 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
01/03/2017 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/Shameek Ghose/ |
SIGNATORY'S NAME |
Shameek Ghose |
SIGNATORY'S POSITION |
Sr. IP Counsel/Head of U.S. Pharma Trademarks & Authorized Corporate Signatory |
DATE SIGNED |
05/24/2018 |
SIGNATORY'S PHONE NUMBER |
(650) 467-1936 |
FILING INFORMATION |
SUBMIT DATE |
Thu May 24 18:07:41 EDT 2018 |
TEAS STAMP |
USPTO/ESU-XX.XX.XXX.XXX-2
0180524180741764529-87146
154-610dc1f65bee53bb8874b
505c7ac11922fb602e7f6eb4f
897cf51d1a8ccdf91ca4-DA-8
066-20180524180438655841 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: TASPIANCE
SERIAL NUMBER: 87146154
The applicant, GENENTECH, INC., having an address of
1 DNA WAY
SOUTH SAN FRANCISCO, California 94080-4990
United States
650-467-1936
650-952-9881
docketing-d@gene.com (authorized)
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 01/03/2017.
For International Class 005:
Current identification: Pharmaceutical preparations for treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases
and disorders, ocular diseases and disorders, inflammatory diseases and disorders, gastro-intestinal diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders,
infectious diseases and disorders, metabolic diseases and disorders
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Shameek Ghose/ Date Signed: 05/24/2018
Signatory's Name: Shameek Ghose
Signatory's Position: Sr. IP Counsel/Head of U.S. Pharma Trademarks & Authorized Corporate Signatory
Signatory's Phone: (650) 467-1936
RAM Sale Number: 87146154
RAM Accounting Date: 05/25/2018
Serial Number: 87146154
Internet Transmission Date: Thu May 24 18:07:41 EDT 2018
TEAS Stamp: USPTO/ESU-XX.XX.XXX.XXX-2018052418074176
4529-87146154-610dc1f65bee53bb8874b505c7
ac11922fb602e7f6eb4f897cf51d1a8ccdf91ca4
-DA-8066-20180524180438655841